443777-10-4Relevant articles and documents
HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS
-
Page/Page column 27; 28; 35; 44, (2016/08/17)
The invention provides compounds that inhibit monocarboxylate transporters, such as MCT1 and MCT4. Compounds of the invention can be used for treatment of a condition in a patient, wherein the condition is characterized by the heightened activity or by the high prevalence of MCT1 and/or MCT4, such as cancer or type II diabetes.